Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-243-4 | CAS number: 931-87-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- not specified
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Cyclohexene
- EC Number:
- 203-807-8
- EC Name:
- Cyclohexene
- Cas Number:
- 110-83-8
- IUPAC Name:
- cyclohexene
- Details on test material:
- Purity 98.6%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 50, 150, 500 mg/kg bw/d
Basis:
no data
Examinations
- Parental animals: Observations and examinations:
- Clinical observation performed and frequency: General condition was
observed once a day, body weights were determined at days 1 (before
dosing),8,15,22,29,36,43 and 49 of treatment for males and at days 1, 8
and 15 of treatment and at days 0,7,14,and 20 of gestation period and at
days 0 and 4 of lactation period and at autopsy for females, food
consumption was determined at days 1,8,15,22,29,36,43 and 48 of
treatment for males and at days 1,8 and 15 of treatment and at days 0,
7,14 and 20 of gestation period and at days 0 and 4 of lactation for
females. but food consumption were not determined during mating period
for males and females.
For 5 males per group, urinalysis was carried out at 43-48 days of administration period. For all males and all females after childbirth per group, hematology and biochemistry were carried out at time of necropsy
after 49 days for males and at 5 days after delivery for females. - Postmortem examinations (parental animals):
- Organs
examined at necropsy.
Organ weight: Brain, liver, kidney, spleen, adrenal, thymus, testis and
epididymis
Microscopic examination: Brain, pituitary, thymus, thyroid, parathyroid,
adrenal, spleen, heart, thoracic aorta, tongue, esophagus, stomach, liver,
pancreas, duodenum, jejunum, ileum, cecum, colon, rectum, larynx,
trachea, lung, kidney, urinary bladder, testis, epididymis, prostate, seminal
vesicle, ovary, uterus, vagina, eye, harderian gland, mammary gland, skin,
sternum, femur, spinal cord, skeletal muscle, mesentery lymph node,
mandibular lymph node, submandibular gland, sublingual gland, parotid
gland, ischiadic nerve, bone marrow. - Statistics:
- Dunnett's test for continuous data and Steel test for quantal data.
- Reproductive indices:
- No.of pairs with successful
copulation, No. of pregnant females, copulation index (No. of pairs with
successful copulation/No. of pairs mated x 100), fertility index (No. of
pregnant animals/No.of animals with successful copulation x 100), estrous
cycle, No. of dams delivered live pups, duration of gestation, No. of total
corpora lutea, No. of total implants, No. of total pups born, No. of total live
pups born, sex ratio, No. of total dead pups, No. of total cannibalism,
gestation index (No. of females with live pups/No. of pregnant females x
100), implantation index (No. of implants/No.of corpora lutea x 100), - Offspring viability indices:
- delivery index (No. of pups born/No. of implants x 100), live birth index (No.
of live pups born/No. of pups born x 100), and viability index on day 4 (No.
of live pups on day 4 after birth/No. of live pups born x 100).
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
Details on results (P0)
Clinical signs: Salivation was apparent in three animals of 150 mg/kg bw group and in twelve animals of 500 mg/kg bw group for males and in two
animals of 150 mg/kg bw group and twelve animals of 500 mg/kg bw group for females. Although the grades of salivation were not reported, the sign was observed for about 5 minutes after dosing at 150 mg/kg bw , and for 30 minutes to 5 hours after dosing at 500 mg/kg bw during treatment
period. In addition, lacrimation was observed in two animals of 500 mg/kg bw group for males and in one animal each of 150 and 500 mg/kg bw
groups for females. The onsets and grades of lacrimation were not reported.
Body weight: No statistically significant changes for males and females.
Food consumption: No effects for males and females.
Urinalysis: No statistically significant changes.
Hematology: No effects for males and females
Blood biochemistry:
Males: Decreases in triglyceride in 150 and 500 mg/kg bw groups, increases in total bilirubin in 500 mg/kg bw group, and total bile acid in 150 and 500 mg/kg bw.
Females: Increase in total bile acid in 50, 150, and 500mg/kg bw.
Necropsy and histopathology: No adverse effects for males and females.
Organ weights:
Males: Increase in a relative kidney weight in 500 mg/kg bw group.
Females: No statistically changes.
Histopathology: No changes related to test substance.
Reproductive and developmental parameters: No effects observed on reproductive performance in males and females given each dose, and developmental performance of the newborns.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- > 500 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 500 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Summary of reproductive performance in rats treated orally with cyclohexene in the combined repeat dose and reproductive/developmental toxicity screening test
Dose level (mg/kg) |
0 |
50 |
150 |
500 |
No, of pairs mated |
12 |
12 |
12 |
12 |
No. of pairs copulated |
12 |
11 |
12 |
12 |
No. of pregnant females |
11 |
10 |
10 |
10 |
Copulation index (%)a |
100.0 |
91.7 |
100.0 |
100.0 |
Fertility index (%)b |
91.7 |
90.9 |
83.3 |
83.3 |
Estrous cycle |
|
|
|
|
No. of animals examined |
12 |
12 |
12 |
12 |
Mean estrous cycle (days, Mean t S.D.) |
4.1 ± 0.1 |
4.1 ± 0.3 |
4.2 ± 0.4 (11) |
4.1 ± 0.3 |
Irregular cyclec(%)d |
0(0.0) |
0(0.0) |
1(8.3) |
2 (16.7) |
a) (No, of animals with successful copulatiun/no. of animals mated)x100
b) (No. of pregnant animals/nm. of animals with successful copulation) x100 c) (No. of unimals having irregular estrous cycle
d) (No. of animals having irregular estrous cycle/no.of animals examined) X100 Values in parentheses are expresser" no. of animals observed
Findings of delivery in dams treated orally with cyclohexene and observations an their pups(F1)in thecombined repeat dose and reproductive/developmental toxicity screening test |
|||||
Dose level (mg/kg) |
0 |
50 |
150 |
500 |
|
No. of dams observed |
11 |
10 |
10 |
10 |
|
No. of dams delivered live pups |
11 |
10 |
10 |
10 |
|
Duration of gestation (Mean ± SD) |
22.5 ± 0.5 |
22.2 -± 0.4 |
22.3 ± 0.5 |
22.5 ± 0.5 |
|
No. of total corpora lutea (Mean ± SD) |
211(19.2 ± 2,6) |
174 (17.4 ± 3.3) |
184(18.4 ± 3.2) |
201(20.1 ± 3.8) |
|
No. of total implants (Mean ± SD) |
151 (13.7 ± 3.0) |
144 (14.4 ± 1.6) |
143 (14.3 ± 1.5) |
143(142 ±1.6) |
|
Ne. of total pups bora (Mean ± SD) |
144(13.1 ± 3.5) |
135 (13.5 ± 1.6) |
139(13.9 ± 1.4) |
128(12.8 ± 1.5) |
|
No. of total live pups born (Mean ± SD) |
141 (12.8 ± 3.5) |
134 (13.4 ± 1.6) |
135(13.5 ± 2,1) |
125(12.5 ± 2.2) |
|
Male |
62( 5.6 ± 1.9) |
72 ( 72 ± 2.0) |
67 (0.7 ± 2.6) |
51(5.1 ± 1.9) |
|
Female |
79( 7.2 ± 2.3) |
62( 6.2 ± 1.9) |
68 (6.8 ± 2.3) |
74( 7.4 ± 2.4) |
|
Sex ratio(Male/ Female, (Mean ± SD) |
0.80 ± 0,23 |
1.32 ± 0.68 |
1.14 ± 1.60 |
0.81 ± 0.56 |
|
No. of total live pups on day 4 (Mean ±SD) |
|
|
|
|
|
Male |
51( 5.5 ± 2,2) |
69( 69±2.1) |
67( 6.7 ± 2.6) |
59( 5.0±2.1) |
|
Female |
75( 6.8 ± 2,8) |
62( 6,2 ± 1.9) |
67( 6.7 ± 2.4) |
72( 7.2±2.0) |
|
No. of total dead pups (Mean ± SD) |
3( 0.3 ± 0.6) |
1( 0.1 ± 0.3) |
1( 0.1 ± 0.3) |
3( 0.3 ± 0.9) |
|
No. of total cannibalism (Mean ± SD) |
0( 0.0 ± 0.0)f |
0( 0.0 ± 0.0)f |
3( 0.3 ± 0.9)f |
0( 0.0 ± 0.0)f |
|
Gestation index(%)a |
100.0 |
100.0 |
100.0 |
100.0 |
|
Implantation index (%, Mean SD)b |
73.2 ± 202 |
84.1 ± 93 |
79.0 ± 10.6 |
72.9 ± 13,1 |
|
Delivery Index (%, Mean±SD)c |
93.2 ± 11.9 |
93.8 ± 6.1 |
97.3 ± 4.7 |
90.0 ± 10.3 |
|
Live birth index (%, Mean ± SD)d |
98.0 ± 4.7 |
99.3 ± 2,3 |
96.9 ± 9.7 |
97.0± 9.5 |
|
Viability index on day 4 (%, Mean ± S.D.)e |
|
|
|
|
|
Male |
90.9 ± 30.2f |
95.3 ± 10.0f |
100.0 ± 0.0f |
96.7 ± 10.5f |
|
Fernale |
88.6 ± 29.8f |
100.0 ± 0.0f |
98.3 ± 5.3f |
98.3 ± 5.3f |
Applicant's summary and conclusion
- Conclusions:
- No adverse effects regarding fertility or development. The NOAEL was 500 mg/kg bw/day regarding reproductive endpoints.
- Executive summary:
The study was conducted according to the OECD combined repeated dose toxicity study with the reproduction/developmental toxicity screening test guideline [TG 422].
Cyclohexene was administered to SD(Crj:CD)IGS rats by gavage at doses of 0, 50, 150 and 500 mg/kg b.w./day for 48 days from 14 days prior to mating in males and for 42-53 days from 14 days prior to mating to day 4 of lactation throughout the mating and pregnancy period in females.
Regarding the reproductive ability of parent animals, no effects were detected on the estrus cycle, copulation index, fertility index, gestation length, numbers of corpora lutea and implantations, implantation index, gestation index, delivery index, parturition or maternal behavior. And regarding the developmental parameters, no effects were detected on viability, body weight, general
appearance or autopsy findings of offspring. The NOAEL for reproduction/developmental toxicity was considered to be 500 mg/kg bw/day, the highest dose tested.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.